Nov 21, 2016 13:00 pm UTC| Business
LOUISVILLE, Ky., Nov. 21, 2016 -- Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on inhibition of the complement system, announced today it will present data from Phase 1 clinical...
Westmoreland Announces CFO Transition
Nov 21, 2016 13:00 pm UTC| Business
ENGLEWOOD, Colo., Nov. 21, 2016 -- Westmoreland Coal Company (Nasdaq:WLB), announced today that its Chief Financial Officer and Treasurer, Jason Veenstra, has decided to resign from Westmoreland effective December 15,...
IGC Appoints John Cherin as CFO, Treasurer and PAO
Nov 21, 2016 13:00 pm UTC| Business
BETHESDA, Md., Nov. 21, 2016 -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announces that on November 15, 2016 it appointed Mr. John (Giovanni) Cherin to the position of CFO, Treasurer and Principal Accounting...
Nov 21, 2016 13:00 pm UTC| Business
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 21, 2016 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced two...
Nov 21, 2016 13:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., Nov. 21, 2016 -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that preliminary clinical data from its lead CDK4/6 inhibitor G1T28 for patients with small-cell...
ARIN Appoints Farsight Security CTO Merike Käo To Board of Trustees
Nov 21, 2016 13:00 pm UTC| Business
SAN MATEO, Calif., Nov. 21, 2016 -- Farsight Security, Inc., provider of the world’s largest real-time DNS threat intelligence, today announced that the American Registry for Internet Numbers (ARIN) Board of Trustees...
Partial Clinical Hold Lifted and Enrollment Resumes for Aduro Biotech LADD Clinical Trials
Nov 21, 2016 13:00 pm UTC| Business
BERKELEY, Calif., Nov. 21, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the U.S. Food and Drug Administration (FDA) has...